Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial. - Bernaudin F; Verlhac S; Ducros-Miralles E; Arnaud C; Genty I; Petras M; Paillard C; De Luna G; Meunier B; Thuret I; Kamdem A; Pondarré C; et al. (American journal of hematology, 2026)